[Immuno-oncologic monitoring of patients with bronchial carcinoma. III. Plasma glycoproteins].
Alpha and beta serum glycoprotein levels were determined in lung cancer patients at time of diagnosis and during the natural course of the disease. The results do not suggest that these glycoproteins can be used as tumour markers. Moreover, some glycoproteins, which have activity in cell-mediated processes and macrophage functions, can suggest prognosis.
D001984:Bronchial Neoplasms / Q000097:blood* / Q000276:immunology; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D007111:Immunity, Cellular; D008259:Macroglobulins / Q000097:blood; D008991:Monitoring, Physiologic; D010587:Phagocytosis; D011379:Prognosis
D006023:Glycoproteins; D008259:Macroglobulins
Monitoraggio immuno-oncologico di pazienti affetti da carcinoma bronchiale. Nota III. Le glicoproteine plasmatiche.